Press release
Rising Infectious Disease Incidences Drive Growth In The Multivalent Vaccine Market: A Key Driver Powering Multivalent Vaccines Market Growth In 2025
Multivalent Vaccines
What Is the Current Multivalent Vaccines Market Size and Its Estimated Growth Rate?
The multivalent vaccines market size will grow from $8.37 billion in 2024 to $9.2 billion in 2025, at a CAGR of 10.0%. Growth drivers include rising public awareness of vaccination, increased government support, higher demand for pediatric multivalent vaccines, increased vaccine research funding, and growing demand for multivalent vaccines.
The multivalent vaccines market is projected to reach $13.32 billion by 2029, at a CAGR of 9.7%. Growth is driven by the rising incidence of infectious diseases, aging population, government and private investment, focus on vaccine safety and effectiveness, and emphasis on therapeutic vaccines. Trends include combination vaccines, digital health technologies, mRNA technology, personalized vaccines, and increased research act
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19120
How Are Emerging Segments Shaping the Multivalent Vaccines Market Landscape?
The multivalent vaccinesmarket covered in this report is segmented -
1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines
2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus
3) By Route Of Administration: Oral, Injectable
4) By Age Group: Pediatrics, Adults, Geriatrics
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines
2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines
3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines
4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines
5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19120&type=smp
Which Growth Factors Are Influencing Multivalent Vaccines Market Expansion?
The increasing incidence of infectious diseases is projected to fuel the growth of the multivalent vaccines market. Infectious diseases, which spread through pathogens like bacteria and viruses, are on the rise, aided by global travel. Multivalent vaccines provide broad protection by targeting multiple pathogen strains in one shot, reducing the need for separate doses. In April 2024, the UK reported an increase in malaria cases, highlighting the need for multivalent vaccines. Hence, the rising prevalence of infectious diseases is boosting the multivalent vaccines market.
Who Are the Dominant Players Across Different Multivalent Vaccines Market Segments?
Major companies operating in the multivalent vaccines market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc.
What Multivalent Vaccines Market Trends Are Gaining Traction Across Different Segments?
Leading companies in the multivalent vaccines market are focused on the development of advanced pentavalent vaccines to offer wider protection with a single dose, thereby improving public health outcomes. A pentavalent vaccine is designed to protect against five different pathogens or strains. By combining these protections into one vaccine, immunization schedules are simplified, and vaccine coverage is enhanced. For example, Panacea Biotec Ltd., based in India, introduced EasyFourPol in December 2023, which is the world's first fully liquid vaccine to protect against five serious diseases, including diphtheria, tetanus, pertussis, polio, and invasive infections from Haemophilus influenzae Type B. This vaccine eliminates the need for preparation by TH*Care workers, streamlines the vaccination process, reduces clinic visits, and lowers immunization costs while minimizing environmental impact by reducing the need for vials, syringes, and packaging.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/multivalent-vaccines-global-market-report
Which Geographic Regions Are Expected to Dominate the Multivalent Vaccines Market in the Coming Years?
North America was the largest region in the multivalent vaccines market in 2024. The regions covered in the multivalent vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Multivalent Vaccines Market?
2. What is the CAGR expected in the Multivalent Vaccines Market?
3. What Are the Key Innovations Transforming the Multivalent Vaccines Industry?
4. Which Region Is Leading the Multivalent Vaccines Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Infectious Disease Incidences Drive Growth In The Multivalent Vaccine Market: A Key Driver Powering Multivalent Vaccines Market Growth In 2025 here
News-ID: 4048025 • Views: …
More Releases from The Business Research Company
Rocket Contamination Control Market Trends That Will Shape the Next Decade: Insi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Rocket Contamination Control Market Size By 2025?
There has been considerable growth in the rocket contamination control market size recently. The market, which is expected to surge from $1.47 billion in 2024 to $1.59 billion in 2025, is predicted to have a compound annual growth…
Increasing Space Exploration Activities Fueling The Growth Of The Market Due To …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Rocket Acoustic Suppression Systems Industry Market Size Be by 2025?
In recent years, there has been a significant increase in the market size of rocket acoustic suppression systems. The market, which is anticipated to increase from $1.44 billion in 2024 to $1.57 billion in 2025, is…
Rocket Combustion Stability Market: Major Trends Reshaping the Future of the Ind …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Rocket Combustion Stability Industry Market Size Be by 2025?
In recent times, there has been swift growth in the market size of rocket combustion stability. Projected to rise from $1.17 billion in 2024 to $1.29 billion in 2025, it has a compound annual growth rate (CAGR)…
Rising Defense Budgets Fueling The Growth Of The Market Due To Increasing Invest …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Rocket And Missile Fuzes Market Through 2025?
The market for rocket and missile fuzes has seen robust expansion in the recent years. The industry size is projected to rise from its $1.06 billion mark in 2024 to reach $1.16 billion by 2025,…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
